Front Pharmacol November 2018 PMID 30534073

A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans.

Sophie A Millar, Nicole L Stone, Andrew S Yates, Saoirse E O'Sullivan

Full text PDF Download social card

Mentions

Peak: 4 in May 2019

across 5 sources since May 2019

Extended reach

68,964

potential audience

Total likes

460

Video views

11,922

Mentions per month

May 2019 – Aug 2024

Where it's discussed

X / Twitter18 posts
News18 articles
Blogs5 articles
YouTube4 videos
Reddit2 posts

AI synopsis

What people are saying

The discussions show a keen interest in how the review highlights gaps like inconsistent data on CBD’s bioavailability and the need for more research, with some criticizing the terminology used and others considering the practical implications for CBD delivery routes. Words like 'helpful,' 'useful,' and questions about administration methods reflect a thoughtful engagement with the article's scientific and practical relevance.

AgreementModerate agreement

Most discussions acknowledge the importance of the review and its findings, with some pointing out the need for better data on CBD pharmacokinetics.

InterestHigh interest

Posts demonstrate high curiosity, discussing the pharmacological aspects, administration routes, and terminology used in the article.

EngagementModerate engagement

Participants reference specific scientific concepts like bioavailability, pharmacokinetics, and research implications, indicating moderate depth in engagement.

ImpactModerate impact

The reviews seem to recognize the potential influence of this research on understanding CBD’s therapeutic applications and delivery methods.

Abstract in brief

This systematic review examines the pharmacokinetics of cannabidiol (CBD) in humans, highlighting limited and inconsistent data despite its widespread use.
Key findings include a wide range of half-life estimates (14 to 109 hours) and a bioavailability of 31% following smoking, but there's a lack of comprehensive data on CBD's absolute bioavailability through other administration routes.
The review underscores the need for more detailed and consistent research on CBD pharmacokinetics to improve its therapeutic applications, emphasizing the importance of understanding factors like bioavailability and half-life.

Read the full abstract

All mentions

Impact of Cannabis Compound Changes on Health and Medicine

This video presents an analysis of cannabis and cannabinoids. It explores the pharmacological properties of CBD, the extraction process, and discusses health impacts associated with THC use. Additionally, it reviews how…

Thibault Fiolet · Nov 21, 2021 10,646 views

Understanding the Therapeutic Potential of CBD Oils

Nowadays it seems like you can find CBD in just about anything with claims that it can cure all sorts of ailments. This video explores CBD oils derived from Cannabis sativa, their approved use for epilepsy, and…

bioZone · May 29, 2022 644 views

Cannabidiol Interactions with Medications and Substances

This video discusses the increasing use of cannabidiol (CBD), its legal status, and potential interactions with medications, alcohol, and other substances. Understanding these interactions is vital for safe consumption…

Pharmacopola Wydawnictwo · Oct 2, 2022 563 views

Optimal CBD Dosage Based on Scientific Research and Pharmacokinetics

This video presents scientific information on the use and optimal doses of CBD for humans. It discusses how individual factors influence dosing, the variability in pharmacokinetics, and emphasizes the importance of…

Healthy Vitalidad · Apr 28, 2023 71 views

Legalizziamo!

@parliamdidroghe · X

RT @meccanismo: Nota: l’articolo doi: 10.3389/fphar.2018.01365 usa impropriamente il termine psicotomimetico. La loro citazione è da https:…

Aug 8, 2024 · 1 share · 5,232 followers View post →

Legalizziamo!

@parliamdidroghe · X

RT @meccanismo: doi: 10.3389/fphar.2018.01365 hundred phytocannabinoid compounds, including the non-psychotomimetic compound cannabidiol (C…

Aug 8, 2024 · 1 share · 5,232 followers View post →

Giuliano Gavazzi

@meccanismo · X

Nota: l’articolo doi: 10.3389/fphar.2018.01365 usa impropriamente il termine psicotomimetico. La loro citazione è da https://t.co/JeVfFWJvF6 che afferma: CBD, a major non-psycotropic cannabinoid.

Aug 7, 2024 · 1 like · 1 share · 665 followers View post →

Giuliano Gavazzi

@meccanismo · X

doi: 10.3389/fphar.2018.01365 hundred phytocannabinoid compounds, including the non-psychotomimetic compound cannabidiol (CBD)

Aug 7, 2024 · 2 likes · 1 share · 665 followers View post →

CBDオタク@初心者の方にも丁寧に解説【CBDに人生全振りした男】

@pot420blog · X

CBD食品を摂取する最高のタイミング

Jan 10, 2023 · 3 likes · 645 followers View post →

CBDオタク@初心者の方にも丁寧に解説【CBDに人生全振りした男】

@pot420blog · X

CBD摂取量のウラ話

Dec 30, 2022 · 8 likes · 645 followers View post →

Herborisia

@Herborisia · X

@AurelienBrnrd @futurasciences https://t.co/XpiBlOgdTf

Jun 6, 2022 · 972 followers View post →

Jenny Robinson, Ph.D.

@jenrobinsonphd · X

@micahgallen This was helpful as we considered various aspects of our CBD crossover trial: https://t.co/hdF0z1Hq0z

Apr 22, 2022 · 1 like · 347 followers View post →

Prof. Dr. Attila Nemeth PhD MBA

@anemeth1965 · X

A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans https://t.co/lDjqhLCplV

Oct 10, 2020 · 187 followers View post →

David

@davidbautistaqf · X

@drpaolandmd El CBD siendo tan hudrofobico y poco biodisponible... Por qué se quiere intentar darlo oral? No tendría más sentido darlo por otras vías como tópica, subcutánea o nasal? https://t.co/O4pQjnLs5T

Sep 22, 2020 · 11,044 followers View post →

SystematicReviewBot

@EvidenceRobot · X

RT @cannabis_hub: Frontiers | A Systematic Review on the Pharmacokinetics of #Cannabidiol in Humans | Pharmacology https://t.co/MsSJMloccp

Sep 14, 2019 · 1 share · 6,709 followers View post →

cannabis innovation hub conference

@cannabis_hub · X

Frontiers | A Systematic Review on the Pharmacokinetics of #Cannabidiol in Humans | Pharmacology https://t.co/MsSJMloccp

Sep 14, 2019 · 1 share · 566 followers View post →

Saoirse E.O'Sullivan

@ScienceSaoirse · X

@TheCannabisCon2 @profhrs Our review on #pharmacokinetics is also useful in understanding routes of #cbd #delivery... https://t.co/rdjlBgcANL

Jul 14, 2019 · 3 likes · 2,256 followers View post →

Ikka Nati Saa ( tuluksilla )

@kokki_saatana · X

A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans https://t.co/jI85tpvu4Q #kannabis #ihminen #systeemit

Jul 7, 2019 · 2 likes · 1 share · 463 followers View post →

Greenthumb_one

@Greenthumb_one · X

RT @CannaApi: A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans ⬇️ https://t.co/nlfrUIiNVi

May 28, 2019 · 2 shares · 4,506 followers View post →

SystematicReviewBot

@EvidenceRobot · X

RT @CannaApi: A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans ⬇️ https://t.co/nlfrUIiNVi

May 28, 2019 · 2 shares · 6,709 followers View post →

API Studio

@CannaApi · X

A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans ⬇️ https://t.co/nlfrUIiNVi

May 28, 2019 · 2 likes · 2 shares · 956 followers View post →

Chimera

@ChimeraGenetics · X

@shecanncannabis https://t.co/toIEJRZi5v

May 27, 2019 · 6 likes · 9,219 followers View post →